Purchases and Sales Made in Q1 2023 in Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS) during Q1 2023. The information is specifically focused on institutions that hold shares of Acumen Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Pathstone Family Office, LLC
Englewood, NJ |
SELL
|
- |
-138K- 26.07% |
$519K - $919K
|
392K
$674K
|
|
May 15, 2023
Q1 2023
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-148K- 50.22% |
$556K - $985K
|
147K
$253K
|
|
May 15, 2023
Q1 2023
|
Guardian Point Capital, LP
Charlottesville, VA |
SELL
|
- |
-170K- 56.67% |
$638K - $1.13M
|
130K
$224K
|
|
May 12, 2023
Q1 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-473K- 41.33% |
$1.77M - $3.15M
|
672K
$1.16M
|